India

After WHO nod for Covaxin, India in touch with more countries for approval: Report | Latest News India

The Ministry of exterior affairs (MEA) has reached out to a variety of countries to safe approval for Covaxin, India’s first indigenous vaccine towards the coronavirus illness (Covid-19), following emergency use itemizing (EUL) from the World Health Organization (WHO), which the jab acquired on November 3. While the MEA is holding discussions with counterparts from numerous countries over the problem, India’s diplomatic missions, too, are in talks with their respective host nations in this regard.

Also Read | WHO offers Covaxin its stamp of approval

“After EUL from the global health body, efforts to get Covaxin recognised have been ramped up. The number of world governments to recognise the vaccine is likely to rise following WHO’s nod,” Hindustan Times’ sister publication Livehindustan reported, citing a media report.

At current, a number of countries permit totally vaccinated Indian nationals to enter with out necessary quarantine upon arrival. However, majority of those have recognised Covishield, the Indian variant of Britain’s AstraZeneca jab. Covaxin, alternatively, has been accepted by practically a dozen nations. From November 8, the United States, too, will permit entry to travellers jabbed with the made-in-India vaccine.

Also Read | List of countries the place Covaxin is cleared

The reported cited by Livehindustan, in the meantime, additional said that the nations contacted by the exterior affairs ministry additionally embody these with whom India has a mutual vaccination certificates.

Also Read | India’s Covid vaccination certificates will get 5 more recognitions, says MEA

Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited, is amongst six jabs getting used in the nationwide vaccination drive, which started on January 16. Along with Covishield, it’s the most generally used vaccine in the drive; these had been additionally the primary two anti-Covid photographs to obtain emergency use authorisation (EUA) from the Drugs Controller General of India (DCGI).

The solely different indigenous vaccine to have been granted EUA by the highest medicine regulator is the Ahmedabad-based Zydus Cadila’s ZyCoV-D.

 

 

Back to top button